A new pioneering Alzheimer’s drug has been rejected for widespread use in the NHS in England.
The announcement comes as the UK’s medicines regulator said that donanemab could be licensed for use in the UK.
However, the health spending watchdog, the National Institute of Health and Care Excellence (NICE), said that it "does not currently demonstrate value for the NHS".
Read more: https://news.sky.com/story/pioneering-alzheimers-drug-rejected-for-widespread-use-in-nhs-in-england-13239378
#alzheimers #health #nhs
SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews
Follow us on Twitter: https://twitter.com/skynews
Like us on Facebook: https://www.facebook.com/skynews
Follow us on Instagram: https://www.instagram.com/skynews
Follow us on TikTok: https://www.tiktok.com/@skynews
For more content go to http://news.sky.com and download our apps: Apple https://itunes.apple.com/gb/app/sky-news/id316391924?mt=8 Android https://play.google.com/store/apps/details?id=com.bskyb.skynews.android&hl=en_GB
Sky News Daily podcast is available for free here: https://podfollow.com/skynewsdaily/
Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí: https://www.youtube.com/channel/UCzG5BnqHO8oNlrPDW9CYJog
To enquire about licensing Sky News content, you can find more information here: https://news.sky.com/info/library-sales